Skip to main content
CIN- L67120MH1995PLC084899
  

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Alembic Pharmaceuticals Ltd.

NSE : APLLTDEQ BSE : 533573 ISIN CODE : INE901L01018Industry : Pharmaceuticals

News

  • Alembic Pharma. - Press Release 14 Nov 2026 | 21:03 | Dion Global

    Alembic Pharmaceuticals Limited receives USFDA Final Approval for Binimetinib Tablets 15 mg and 45 mg.more...

  • Alembic Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release 14 Nov 2026 | 21:03 | Dion Global

    Alembic Pharmaceuticals Limited receives USFDA Final Approval for Binimetinib Tablets 15 mg and 45 mg.more...

  • Alembic Pharma. - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 10 Nov 2026 | 16:35 | Dion Global

    Please find attached herewith the Transcript of Post Results Conference Call held on 4th November 2026.more...

  • Alembic Pharma. - Analysts/Institutional Investor Meet/Con. Call Updates 10 Nov 2026 | 16:34 | Dion Global

    Alembic Pharmaceuticals Limited has informed the Exchange about Transcriptmore...

  • Alembic Pharma gets USFDA final approval for Olopatadine eye drops 05 Nov 2026 | 14:47 | Dion Global

    Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) ...more...

  • Alembic Pharma. - Copy of Newspaper Publication 05 Nov 2026 | 12:32 | Dion Global

    Alembic Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication related to Unaudited Financial Results of the ...more...

  • Alembic Pharma. - Press Release 04 Nov 2026 | 22:00 | Dion Global

    Alembic Pharmaceuticals Limited receives USFDA Final Approval for Olopatadine Hydrochloride Ophthalmic Solution USP 0.7% (OTC).more...

  • Alembic Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release 04 Nov 2026 | 21:57 | Dion Global

    Alembic Pharmaceuticals Limited receives USFDA Final Approval for Olopatadine Hydrochloride Ophthalmic Solution USP 0.7% (OTC).more...

  • Alembic Pharma. - Analysts/Institutional Investor Meet/Con. Call Updates 04 Nov 2026 | 19:03 | Dion Global

    Alembic Pharmaceuticals Limited has informed the Exchange about Link of Audio Recordingmore...

  • Alembic Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 04 Nov 2026 | 19:01 | Dion Global

    Please find attached Audio Recording of Investor Call.more...

  • Alembic Pharma. - Updated Contact Details Of Key Managerial Personnel Pursuant To Regulation 30(5) Of SEBI (Listing Obligatio 04 Nov 2026 | 15:12 | Dion Global

    Please find attached intimation under Regulation 30(5) of SEBI (LODR) Regulations 2015.more...

  • Alembic Pharma. - General Updates 04 Nov 2026 | 15:12 | Dion Global

    Alembic Pharmaceuticals Limited has informed the Exchange about General Updates: Updated Details of Key Managerial Personnel pursuant to Reg...more...

  • Alembic Pharma. Q2 net profit zooms 128.23% at Rs 409.36 cr 04 Nov 2026 | 15:00 | Dion Global

    The company reported standalone net profit of Rs 409.36 crore for the quarter ended September 30 2026 as compared to Rs 179.36 crore in the same peri...more...

  • Alembic Pharma. - Press Release 04 Nov 2026 | 14:42 | Dion Global

    Please find attached Press Releasemore...

  • Alembic Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release 04 Nov 2026 | 14:41 | Dion Global

    Please find attached Press Releasemore...

  • Alembic Pharma. - Investor Presentation 04 Nov 2026 | 14:39 | Dion Global

    Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentationmore...

  • Alembic Pharma. - Announcement under Regulation 30 (LODR)-Investor Presentation 04 Nov 2026 | 14:38 | Dion Global

    Please find attached Investor Presentation for the Quarter and Half Year Ended September 30 2026.more...

  • Alembic Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release 04 Nov 2026 | 14:35 | Dion Global

    Please find attached Press Release for the Quarter and Half Year Ended September 30 2026.more...

  • Alembic Pharma. - Press Release 04 Nov 2026 | 14:34 | Dion Global

    Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 04 2026 titled Press Release on the Unaudited Fina...more...

  • Alembic Pharma. - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2026 04 Nov 2026 | 14:31 | Dion Global

    Please find attached Unaudited Financial Results for the Quarter and Half Year Ended September 30 2026.more...


Global Indices table showing index names, current values, and percentage changes
Index Name Current Value Direction Change (%)
DOW Jones45473.55Up0.16%
Nasdaq21794.16Up0.43%
S&P 5006496.04Up0.22%
Nikkei 22543643.81Up1.45%
Hang Seng25633.91Up0.85%
Shanghai Composite3826.84Up0.38%

Indian Indices table showing index names, current values, and percentage changes
Index Name Current Value Direction Change (%)
Sensex82104.79Up0.63%
NSE Index25291.1Up0.58%
B500DIVL503481.93Down-0.20%
BSE 1000 11105.65Down-0.07%
BSE 100LCTMC9457.59Up0.37%
BSE Auto 60641.87Down-1.29%

Commodity


Commodity prices table showing commodity names, current prices, and percentage changes
Commodity Name Current Price Direction Change (%)
Gold134176Down-1.19%
Silver169914Down-4.32%
Copper1329.7Up226.07%
Crude Oil8342Up30.08%
Lead196.85Up46.47%
Mentha Oil1448.1Up35.67%
Nickel1531.2Up99.66%

Currency


Currency exchange rates table showing currency pairs, exchange rates, and percentage changes
Currency Pair Exchange Rate Direction
USD/INR94.2000 (0.46%)Up
GBP/INR124.6100 (0.26%)Up
EUR/INR104.1800 (0.32%)Up
JPY/INR0.5900 (0.57%)Up
CAD/INR65.7400 (0.00%)Up
HKD/INR11.9500 (-0.02%)Down